On January 18, 2024, Acadia Healthcare Company, Inc. and the Guarantors entered into that certain Amendment No. 2 to Credit Agreement (the Amendment) with Bank of America, N.A., as administrative agent (the Administrative Agent) and certain lenders party thereto, which amends the Credit Agreement, dated as of March 17, 2021, among the Company, the Administrative Agent and the lenders from time to time party thereto (as previously amended, the Existing Credit Agreement, and the Existing Credit Agreement as amended by the Amendment, the Amended Credit Agreement). The Existing Credit Agreement provides for a $600 million senior secured revolving credit facility (the Revolving Facility) and a $425 million senior secured term loan facility (the Existing Term Loan Facility), each maturing on March 17, 2026 unless extended in accordance with the terms of the Existing Credit Agreement.

The Amendment provides for the incurrence of additional senior secured term loans in an aggregate principal amount of $350 million (the Incremental Term Loans). Such Incremental Term Loans are structured as an increase of the Existing Term Loan Facility. The maturity date, the leverage-based pricing grid, amortization, mandatory prepayment events and other terms applicable to the Incremental Term Loans are substantially identical to those applicable to the Existing Term Loan Facility that were in effect prior to the Amendment.

After giving effect to the Amendment and the Incremental Term Loans, borrowings under the Amended Credit Agreement bear interest at a floating rate equal to, at the option of the Company, (i) adjusted SOFR plus 1.50% or (ii) an alternative base rate plus 0.500% (in each case, subject to future adjustment based on changes to the company?s consolidated total net leverage ratio).